GlassScriptPhysician profile
Angela White
NPI 1114277944
$1,680.70
in general payments reported to CMS, 2019-2025
10 companies · $1,115 in 2025
The $1,115 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.54 · 2022: $178 · 2023: $325 · 2024: $13.15 · 2025: $1,115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $773 · Travel and Lodging: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.96 |
| Travel and Lodging | $679.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $837.76 | 2025 | Synchromedii |
| W. L. Gore & Associates, INC. | $140.07 | 2023 | Gore Viabahn Endoprosthesis With Heparin |
| Amgen INC. | $133.80 | 2022 | |
| Abbvie INC. | $126.39 | 2021-2025 | |
| Phathom Pharmaceuticals, INC. | $123.66 | 2025 | Voquezna |
| Collegium Pharmaceutical, INC. | $117.81 | 2023-2025 | Belbuca, Xtampza |
| Scilex Pharmaceuticals INC. | $83.75 | 2022-2024 | Ztlido |
| Novo Nordisk INC | $64.71 | 2025 | Ozempic |
| Lilly USA, LLC | $35.02 | 2021 | |
| Ibsa Pharma INC. | $17.73 | 2023 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.